newsfilter
← Latest News
GlobeNewswire·

Traws Pharma Provides Business Update and Reports Q3 2024 Financial Results

COVID: Phase 1 pharmacokinetic profile supports the potential for ratutrelvir to be dosed as a once-a-day, single drug, 10-day treatment course, without ritonavir, and with a lower likelihood of clinical rebound and good